BioSpace News Archive

Apollo Endosurgery, Inc. announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy and safety of Endoscopic Sleeve Gastroplasty (“ESG”) using Apollo’s OverStitch™ Endoscopic Suturing System, in patients with non-alcoholic steatohepatitis (“NASH”).

Company believes the up-listing process will be completed sometime in Q3

Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency

TP Therapeutics is a clinical-stage biopharmaceutical company developing oncology therapies with a focus on addressing current drug resistance.

Recognized as a finalist in the non-profit category, the Stupid Cancer App provides instant, anonymous peer support and tailored information to anyone impacted by cancer.

Students will present to representatives of the American Heart Association and American Stroke Association, Battelle, the Medical Director of the Ohio Department of Health, and the Ohio Secretary of State.

Urges Shareholders to Vote “FOR” the Ironwood Director Nominees on the WHITE Proxy Card

Dr. Urbanski will report to Shawn Cross, the Company’s Chief Executive Officer.

BRIVIACT CV oral formulations are approved as a monotherapy or adjunctive therapy in patients four years of age and older with partial-onset seizures

MEI Pharma, Inc. today announced it entered into a definitive securities purchase agreement for the sale of its common stock and warrants to purchase common stock in a private placement led by Vivo Capital and CAM Capital.